Correlation Between Walker Dunlop and Mereo BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Mereo BioPharma Group, you can compare the effects of market volatilities on Walker Dunlop and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Mereo BioPharma.

Diversification Opportunities for Walker Dunlop and Mereo BioPharma

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Walker and Mereo is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Walker Dunlop and Mereo BioPharma

Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 14.88 times less return on investment than Mereo BioPharma. But when comparing it to its historical volatility, Walker Dunlop is 2.22 times less risky than Mereo BioPharma. It trades about 0.01 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  236.00  in Mereo BioPharma Group on August 25, 2024 and sell it today you would earn a total of  136.00  from holding Mereo BioPharma Group or generate 57.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.28%
ValuesDaily Returns

Walker Dunlop  vs.  Mereo BioPharma Group

 Performance 
       Timeline  
Walker Dunlop 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Walker Dunlop are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Walker Dunlop is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Walker Dunlop and Mereo BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Walker Dunlop and Mereo BioPharma

The main advantage of trading using opposite Walker Dunlop and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.
The idea behind Walker Dunlop and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stocks Directory
Find actively traded stocks across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments